{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:32:53Z","timestamp":1786991573802,"version":"build-2736575974"},"reference-count":49,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/21645515.2021.1915038","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T15:01:40Z","timestamp":1640790100000},"page":"5325-5333","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry"],"prefix":"10.1080","volume":"17","author":[{"given":"Charlotte","family":"Switzer","sequence":"first","affiliation":[{"name":"Sanofi Pasteur","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilia","family":"Tikhonov","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur","place":["Swiftwater, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Khromava","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitali","family":"Pool","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur","place":["Swiftwater, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-6253","authenticated-orcid":false,"given":"Linda E.","family":"L\u00e9vesque","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,12,29]]},"reference":[{"issue":"4","key":"e_1_3_2_2_1","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among pregnant women and postpartum women and their infants. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","unstructured":"Centers for Disease Control and Prevention (CDC). Preventing tetanus, diphtheria, and pertussis among pregnant women and postpartum women and their infants. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2008;57(RR\u20134):1\u201341.","journal-title":"MMWR"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.11.024"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182093814"},{"issue":"41","key":"e_1_3_2_5_1","first-page":"1424","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunizations Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunizations Practices (ACIP), 2011. MMWR. 2011;60(41):1424\u201326.","journal-title":"MMWR"},{"issue":"7","key":"e_1_3_2_6_1","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women \u2013 Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","author":"Centers for Disease Control Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women \u2013 Advisory Committee on Immunization Practices (ACIP), 2012. MMWR. 2013;62(7):131\u201335.","journal-title":"MMWR"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181b48f07"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31824e1327"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000431054.33593.e3"},{"key":"e_1_3_2_10_1","unstructured":"Medical Dictionary for Regulatory Activities (MedDRA). [accessed 2018 Aug 28]. http:\/\/www.meddra.org."},{"key":"e_1_3_2_11_1","first-page":"52252","article-title":"21 code of federal regulation part 600.80 postmarketing reporting of adverse experiences","volume":"62","author":"US Food and Drug Administration (FDA)","year":"1997","unstructured":"US Food and Drug Administration (FDA). 21 code of federal regulation part 600.80 postmarketing reporting of adverse experiences. Fed Regist. 1997 [accessed 2018 Aug 28];62:52252\u201353. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=600.80.","journal-title":"Fed Regist"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1214\/ss\/1009213286"},{"key":"e_1_3_2_13_1","unstructured":"Center for Disease Control and Prevention (CDC). Data on selected pregnancy complications in the United States. [accessed 2019 Feb 18]. http:\/\/www.cdc.gov\/reproductiveheatlh\/maternalinfanthealth\/pregnancy-complications.html."},{"key":"e_1_3_2_14_1","unstructured":"US Department of Health and Human Services National Institute of Child Health and Human Development National Institute of Health. Most common complications of pregnancy. [accessed 2019 Feb 18]. http:\/\/www.nichd.nih.gov\/health\/topics\/pregnancy\/conditioninfo\/complications."},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1016229"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.58888\/pcd11.130415"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2009.12303"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.011"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.071"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.041"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.12790"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001066"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4219"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.14825"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009536"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010911"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1157241"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000862"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.06.021"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.049"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.05.006"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001712"},{"key":"e_1_3_2_33_1","unstructured":"Martin JA Hamilton BE Osterman MJK Driscoll AK Mathews TJ. Births: final data for 2015. National Vital Statistics Reports; 66(1). Hyattsville MD: National Centre for Health Statistics; 2017. [accessed 2019 Feb 18]. http:\/\/www.cdc.gov\/nchs\/data\/nvsr\/vnsr67\/nvsr67_01.pdf."},{"issue":"7","key":"e_1_3_2_34_1","first-page":"1","article-title":"Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990-2008","volume":"60","author":"Ventura SJ","year":"2012","unstructured":"Ventura SJ, Curtin SC, Abma JC, Henshaw SK. Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990-2008. National Vital Stat Rep. 2012;60(7):1\u201321.","journal-title":"National Vital Stat Rep"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.12.038"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.12.026"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000158860.26939.2d"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.06.067"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.130499"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.94"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181f0bc08"},{"key":"e_1_3_2_42_1","unstructured":"American Heart Association. Patent Foramen Ovale (PFO). [accessed 2019 Feb 18]. http:\/\/www.heart.org\/en\/health-topics\/congenital-heart-defects\/about-congenital-heart-defects\/patent-foramen-ovale."},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20735"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01886-7"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(63)90149-9"},{"key":"e_1_3_2_46_1","unstructured":"Stanford Children\u2019s Health. Factors contributing to congenital birth defects [accessed 2019 Feb 23]. http:\/\/www.stanfordchildrens.org\/en\/topic\/default?id=factors-contributing-to-congenital-heart-disease-90-P01788."},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2069.84641"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2069.189119"},{"key":"e_1_3_2_49_1","first-page":"1","article-title":"Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs","volume":"6","author":"Weber JCP","year":"1984","unstructured":"Weber JCP. Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. Adv Inflam Res. 1984;6:1\u20137.","journal-title":"Adv Inflam Res"},{"issue":"53","key":"e_1_3_2_50_1","first-page":"1","article-title":"Summary of notifiable diseases, 2012","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2014","unstructured":"Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases, 2012. MMWR. 2014;61(53):1\u2013121.","journal-title":"MMWR"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1915038","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2021.1915038","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1915038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:22:20Z","timestamp":1786990940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1915038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/21645515.2021.1915038"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1915038","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}